INTANGIBLE ASSETS	9 Months Ended
Sep. 30, 2011
INTANGIBLE ASSETS	NOTE 5 - INTANGIBLE ASSETS At September 30, 2011 and December 31, 2010, intangible assets consisted of customers’ lists arising from the acquisition of Likang Biological, amortized over 5 years. Net intangible assets as of September 30, 2011 and December 31, 2010 totaled $333,871 and $410,918, respectively. Amortization expenses for the nine months ended September 30, 2011 and 2010 were $77,047 and $77,047, respectively. Amortization expenses for the three months ended September 30, 2011 and 2010 were $25,682 and $25,682. Annual amortization expenses for the next five years from September 30, 2011 are expected to be: $102,730, $102,730, $102,730, $25,681 and $0.

INTANGIBLE ASSETS

9 Months Ended

Sep. 30, 2011

NOTE 5 - INTANGIBLE ASSETS

At September 30, 2011 and December 31, 2010, intangible assets consisted of customers’ lists arising from the acquisition of Likang Biological, amortized over 5 years. Net intangible assets as of September 30, 2011 and December 31, 2010 totaled $333,871 and $410,918, respectively. Amortization expenses for the nine months ended September 30, 2011 and 2010 were $77,047 and $77,047, respectively. Amortization expenses for the three months ended September 30, 2011 and 2010 were $25,682 and $25,682. Annual amortization expenses for the next five years from September 30, 2011 are expected to be: $102,730, $102,730, $102,730, $25,681 and $0.